Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
lungcanc
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC
IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology
lungcanc
IASLC WCLC 2017 Presidential Symposium Presents Leading Lung Cancer Research
lungcanc
IASLC 18th World Conference on Lung Cancer
lungcanc
IASLC Workshop in Lung Cancer Clinical Research
lungcanc
ELCC 2017 Unveils New Research Regarding Screening, Immunotherapy, Treatment Planning, and...
lungcanc
2017 ASCO Annual Meeting
lungcanc
Best of the IASLC 17th World Conference on Lung Cancer in...
lungcanc
IASLC Small Cell Lung Cancer Workshop
lungcanc
17th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting
lungcanc
Societies Join Forces to Host Seventh European Lung Cancer Conference
lungcanc
1
...
3
4
5
6
Page 4 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
